Quarterly Consolidated Balance Sheet

Oncolys BioPharma Inc. - Filing #7712871

Concept As at
2018-09-30
As at
2017-12-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
2,389,329,000 JPY
2,867,512,000 JPY
Work in process
JPY
4,931,000 JPY
Other
729,000 JPY
285,000 JPY
Current assets
2,514,927,000 JPY
3,071,713,000 JPY
Non-current assets
Property, plant and equipment
2,759,000 JPY
2,506,000 JPY
Property, plant and equipment
Investments and other assets
827,516,000 JPY
452,002,000 JPY
Investments and other assets
Investment securities
685,403,000 JPY
400,194,000 JPY
Other
19,000 JPY
19,000 JPY
Non-current assets
830,275,000 JPY
454,508,000 JPY
Assets
3,345,203,000 JPY
3,526,222,000 JPY
Liabilities
Current liabilities
Short-term borrowings
83,336,000 JPY
93,336,000 JPY
Income taxes payable
19,586,000 JPY
32,826,000 JPY
Current liabilities
163,012,000 JPY
239,035,000 JPY
Non-current liabilities
Long-term borrowings
319,438,000 JPY
344,440,000 JPY
Non-current liabilities
325,294,000 JPY
355,293,000 JPY
Liabilities
488,306,000 JPY
594,328,000 JPY
Net assets
Shareholders' equity
Share capital
6,203,996,000 JPY
5,802,444,000 JPY
Capital surplus
6,196,496,000 JPY
5,794,944,000 JPY
Retained earnings
-9,561,968,000 JPY
-8,660,016,000 JPY
Shareholders' equity
2,838,523,000 JPY
2,937,371,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
4,092,000 JPY
-15,786,000 JPY
Valuation and translation adjustments
4,092,000 JPY
-15,786,000 JPY
Share acquisition rights
14,280,000 JPY
10,309,000 JPY
Net assets
2,856,896,000 JPY
2,931,893,000 JPY
Liabilities and net assets
3,345,203,000 JPY
3,526,222,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.